StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) stock

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.05+0.01 (+0.25%)

Close on Nov 17, 2026Market cap $336.94MP/E –Yield –

Opus Genetics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Opus Genetics's total debt was $1.20M at Mar 31, 2026. For fiscal 2025 it was $1.13M. The highest annual figure on record is $1.13M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.13M–
FY2024Dec 31, 2024$0–
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$538.00K–
FY2020Dec 31, 2020$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$1.20M–
Q4 FY2025Dec 31, 2025$1.13M–
Q3 FY2025Sep 30, 2025$1.07M–
Q2 FY2025Jun 30, 2025$1.00M–
Q4 FY2024Dec 31, 2024$0-100.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$215.00K–
Q4 FY2021Dec 31, 2021$538.00K–
Q4 FY2020Dec 31, 2020$0–

More Opus Genetics figures

See a number that looks wrong?